Table 4 Serious infectious events to day 197 and day 365
Days 1–197Days 1–365
Abatacept + MTX (n = 156)Placebo + MTX (n = 110)Inflixima + MTX (n = 165)Abatacept + MTX (n = 156)Infliximab + MTX (n = 165)
n (%)n (%)n (%)n (%)n (%)
Total patients with SAEs8 (5.1)13 (11.8)19 (11.5)15 (9.6)30 (18.2)
Infections and infestations2 (1.3)3 (2.7)7 (4.2)3 (1.9)14 (8.5)
Pneumonia2 (1.3)02 (1.2)2 (1.3)3 (1.8)
Sinusitis1 (0.6)001 (0.6)0
Postoperative wound infection01 (0.9)001 (0.6)
Soft tissue abscess01 (0.9)000
Infective bursitis01 (0.9)000
Bronchitis001 (0.6)01 (0.6)
Cellulitis001 (0.6)01 (0.6)
Gastroenteritis001 (0.6)01 (0.6)
Herpes zoster001 (0.6)01 (0.6)
Lung infection pseudomonal001 (0.6)01 (0.6)
Pneumocystis jiroveci pneumonia001 (0.6)01 (0.6)
Infection skin ulcer0001 (0.6)0
Encephalitis herpetic00001 (0.6)
Erysipelas00001 (0.6)
Lobar pneumonia00001 (0.6)
Peritoneal tuberculosis00001 (0.6)
Pulmonary tuberculosis00001 (0.6)
Septic shock00001 (0.6)
  • MTX, methotrexate; SAE, serious adverse event.